– Press Release –
Empowering Healthcare Professionals with
Innovative Literature Solutions from MedCom GmbH
Celebrating 10 Years of Partnership & Innovation
MedCom GmbH celebrates ten-year partnership with Fujifilm in advancing prostate cancer diagnostics
Nov. 2025
Intraoperative radiotherapy
Asklepios Klinik St. Georg introduces new treatment procedure for tumor patients… more
Aug. 2023
MedCom GmbH joins the UniteRT initiative
Madrid, Spain 14th of June 2023 – The membership of MedCom in UniteRT (www.unitert.org), an open & non-profit, robust coalition of Radiation Therapy… more
Jun. 2023
First treatment with Q-PRO® and integrated BiopSee® image management technology
Darmstadt, Germany 15th of December 2022 – The first treatment combining SpectraCure’s next-generation Q-PRO® treatment system and integrated BiopSee®… more
Dec. 2022
IBEX and MedCom join forces to sell a combined scatter correction and reconstruction engine for CBCT applications.
MedCom GmbH (Darmstadt, Germany) and IBEX Innovations Limited (Durham, UK) are pleased to announce a collaboration and marketing agreement to deploy…more
Mar. 2021
Mithilfe von Biomarkern bösartige Lymphknoten diagnostizieren (German)
Ein Darmstädter Forscherteam entwickelt in Kooperation mit der HNO Uniklinik Düsseldorf eine neue Diagnosemethode für bösartige Lymphknoten im…more
Dec. 2019
Precise Diagnosis of the Prostate Gland Gentle and Safe
MRI-guided Stereotactic Prostate Biopsy with BiopSee® and Hitachi ARIETTA V70 true stories by Hitachi Medical Systems Europe
Jan. 2018
The Poster presentation of recotom© the new CBCT algorithm
recotom© the new CBCT algorithm made by MedCom on the PTCOG was a great success. You missed it? Please see here (rectomVeriSuitePosterV2) to find the poster online.
